Aparito - a wholly owned subsidiary of Eli Lilly and Company
Entity

  • Aparito - a wholly owned subsidiary of Eli Lilly and Company

    Created in 2015
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,825 3,550

  • Activities

    healthtech deeptech biotech

  • Technologies

    Data Analytics

  • Entity types

    Startup

  • Location

    11 Bron-Y-Nant, Croesnewydd Rd, Wrexham LL13 7TX, UK

    Wrexham

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 29

  • Engaged corporates

    11
    3 4

  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    Digitising clinical trials and capturing real-world data through mobile apps, video assessments & wearable devices

    Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials.

    We do this through our Atom5TM eCOA platform using video assessments, wearable devices and ePROs to generate continuous real-world data.

    mHealth, Wearables, Patient Engagement, Rare Diseases, Orphan Diseases, Telehealth, Digital Health, Health Technology, Decentralised Clinical Trials, Hybrid Clinical Trials, eCOA, Digital Biomarkers, ePRO, Clinical Trials, vCOA, and Video eCOA

  • Digitizing clinical trials | Aparito

    Aparito digitizes clinical trials and captures real-world data through mobile apps, video assessments & wearable devices.

    • https://www.aparito.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing 		Other

21 Oct 2023


Similar entities
Last news
Show all articles
Social network dynamics